Insights+

PharmaShots’ Key Highlights of First Quarter 2025

PharmaShots’ Key Highlights of First Quarter 2025

Shots:   Q1’2025 highlights major acquisitions in the pharma and...

Disease of the Month – Lennox-Gastaut syndrome (LGS)

Disease of the Month – Lennox-Gastaut syndrome (LGS)

Shots:  Lennox-Gastaut syndrome (LGS) is a severe childhood-onset epile...

New Drug Designations - February 2025

New Drug Designations - February 2025

Shots:     PharmaShots’ Designation Report provide...

Know Your Investor: Perceptive Advisors (March’25 Edition)

Know Your Investor: Perceptive Advisors (March’25 Edition)

Shots:   The March edition highlights Perceptive Advisors, a New York-b...

EMA Marketing Authorization of New Drugs in February 2025

EMA Marketing Authorization of New Drugs in February 2025

Shots:    The EMA’s CHMP has granted positive opinions...

The US FDA New Drug Approvals in February 2025

The US FDA New Drug Approvals in February 2025

Shots:      PharmaShots has compiled a list of US F...

Image